Drug intelligence / Profile preview

Canvert M

Development stage: Preclinical
Lead developer: Alasht Pharmed
Modality: Small Molecules
Administration: Topical

Overview

Canvert M is a cosmeceutical headache relief serum developed by Alasht Pharmed. It is formulated for topical application, typically to the forehead or temples, to provide symptomatic relief from headaches. As a cosmeceutical, it represents a category of products that combine cosmetic properties with therapeutic benefits. While the specific active ingredients are not publicly disclosed, the serum is part of the company's pipeline focused on pain management and specialized topical treatments.

Brand names: Canvert M
Other names: Canvert M

Beyond the preview

Go deeper on Canvert M.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Canvert M.

Explore the full profile